Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$338M |
| 2 |
Visa
V
|
+$279M |
| 3 |
Microsoft
MSFT
|
+$277M |
| 4 |
Union Pacific
UNP
|
+$277M |
| 5 |
SIVB
SVB Financial Group
SIVB
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$440M |
| 2 |
Palo Alto Networks
PANW
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$281M |
| 4 |
Cognizant
CTSH
|
+$280M |
| 5 |
CrowdStrike
CRWD
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.5% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.23% |
| 4 | Industrials | 11.12% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
NexGen Energy
NXE
$7.08B
| $150K | ﹤0.01% |
33,960
-29
| -0.1% | -$121 |
|
|
DPG
3627
Duff & Phelps Utility and Infrastructure Fund
DPG
$517M
| $149K | ﹤0.01% |
11,028
+7
| +0.1% | +$93 |
|
|
HLTH
3628
DELISTED
Cue Health Inc. Common Stock
HLTH
| $147K | ﹤0.01% |
71,010
+54,891
| +341% | +$173K |
|
3629
Veru
VERU
$47.6M
| $145K | ﹤0.01% |
2,747
-269
| -9% | -$22.1K |
|
3630
Codexis
CDXS
$159M
| $144K | ﹤0.01% |
30,935
+1,645
| +6% | +$9.02K |
|
|
CVAC
3631
DELISTED
CureVac
CVAC
| $143K | ﹤0.01% |
23,776
-318
| -1% | -$2.35K |
|
|
ROVR
3632
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $143K | ﹤0.01% |
39,014
-3,684
| -9% | -$15.8K |
|
|
BHIL
3633
DELISTED
Benson Hill, Inc.
BHIL
| $143K | ﹤0.01% |
1,600
-99
| -6% | -$9.7K |
|
|
NUTX
3634
Nutex Health
NUTX
$1.14B
| $142K | ﹤0.01% |
498
+385
| +341% | +$73.9K |
|
3635
Akebia Therapeutics
AKBA
$240M
| $142K | ﹤0.01% |
245,507
-5,017
| -2% | -$1.57K |
|
|
DSEY
3636
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $141K | ﹤0.01% |
33,015
-3,236
| -9% | -$15.8K |
|
|
DZSI
3637
DELISTED
DZS Inc. Common Stock
DZSI
| $139K | ﹤0.01% |
+10,928
| New | +$139K |
|
3638
Caribou Biosciences
CRBU
$168M
| $135K | ﹤0.01% |
21,541
-293,511
| -93% | -$2.61M |
|
|
SLGC
3639
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $134K | ﹤0.01% |
53,253
-713
| -1% | -$1.99K |
|
3640
SmartRent
SMRT
$270M
| $133K | ﹤0.01% |
54,903
-4,638
| -8% | -$11.5K |
|
3641
Identive
INVE
$62.4M
| $133K | ﹤0.01% |
+18,370
| New | +$178K |
|
|
SRNE
3642
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $133K | ﹤0.01% |
149,982
+27,971
| +23% | +$37.1K |
|
|
VIEW
3643
DELISTED
View, Inc. Class A Common Stock
VIEW
| $133K | ﹤0.01% |
2,290
-112,354
| -98% | -$8.21M |
|
3644
Banco Bradesco
BBD
$35B
| $132K | ﹤0.01% |
45,915
-646
| -1% | -$2.09K |
|
|
USER
3645
DELISTED
UserTesting, Inc.
USER
| $131K | ﹤0.01% |
17,384
-174,288
| -91% | -$1.12M |
|
|
NGMS
3646
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $130K | ﹤0.01% |
+10,705
| New | +$161K |
|
3647
The Beachbody Company
BODI
$45.8M
| $130K | ﹤0.01% |
4,925
+1
| +0% | +$43 |
|
3648
Custom Truck One Source
CTOS
$2.42B
| $128K | ﹤0.01% |
20,242
-505
| -2% | -$3.27K |
|
3649
Grupo Aval
AVAL
$6.24B
| $128K | ﹤0.01% |
50,558
-3,127
| -6% | -$7.23K |
|
3650
Rush Street Interactive
RSI
$2.91B
| $127K | ﹤0.01% |
35,298
+9,411
| +36% | +$34.9K |
|
Similar funds
Invesco's Q4 2022 Portfolio in Review
As of Q4 2022, Invesco held 4,129 positions worth $341B, up 9.9% from $311B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Invesco's Q4 2022 filing shows 147 new, 2,069 increased, 1,601 reduced and 115 closed positions. Its largest new stake was British American Tobacco: 3,556,143 shares worth $142M. The largest sale was UnitedHealth, an estimated $440M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q4 2022 buy was British American Tobacco: 3,556,143 shares worth $142M.
- Invesco added most to NVIDIA in Q4 2022, an estimated $338M increase.
- Invesco's biggest Q4 2022 reduction was UnitedHealth, cutting an estimated $440M.
- Invesco fully exited Duke Realty Corp. in Q4 2022, selling an estimated $131M.
- Invesco's ten largest holdings make up 10% of its $341B portfolio in Q4 2022.
- Invesco opened 147 new positions and closed 115 in Q4 2022.
- Invesco's portfolio value rose 9.9% quarter-over-quarter to $341B.
Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.